1. Silvestri V, Mushi V, Ngasala B. Hydatidosis. In: Silvestri V, Mushi V, Ngasala B, editors.Vascular Damage in Neglected Tropical Diseases: A Surgical Perspective. Cham: Springer Nature Switzerland; 2024. p. 33–48.
2. Hogea M-O, Ciomaga B-F, Muntean M-M, Muntean A-A, Popa MI, Popa GL. Cystic echinococcosis in the early 2020s: A review. Trop med infect 2024; 9: 36.
3. Calame P, Weck M, Busse-Cote A, Brumpt E, Richou C, Turco C, et al. Role of the radiologist in the diagnosis and management of the two forms of hepatic echinococcosis. Insights Imaging 2022; 13: 68.
4. Basinger SC, Khan A, Ahmed H, Afzal MS, Simsek S, Budke CM. Estimation of the monetary burden of treated human cystic echinococcosis in Pakistan. Acta Trop 2021; 222: 106026.
5. Aziz H, Seda P, Aswani Y, Gosse MD, Krishnakumari AJ, Pawlik TM. Cystic echinococcosis of the liver. J Gastrointest Surg 2025; 29: 101974.
6. Widdicombe J, Basáñez M-G, Entezami M, Jackson D, Larrieu E, Prada JM. The economic evaluation of cystic echinococcosis control strategies focused on zoonotic hosts: A scoping review. PLoS Negl Trop Dis 2022; 16: e0010568.
7. Gessese AT. Review on epidemiology and public health significance of hydatidosis. Vet Med Int 2020; 2020:8859116.
8. Fakhri Y, Omar SS, Dadar M, Pilevar Z, Sahlabadi F, Torabbeigi M, et al. The prevalence of hydatid cyst in raw meat products: A global systematic review, meta-analysis, and meta-regression. Sci Rep 2024; 14: 26094.
9. Sadr S, Lotfalizadeh N, Abbasi AM, Soleymani N, Hajjafari A, Roohbaksh Amooli Moghadam E, et al. Challenges and prospective of enhancing hydatid cyst chemotherapy by nanotechnology and the future of nanobiosensors for diagnosis. Trop Med Infect Dis 2023; 8: 494.
10. Ezzatkhah F, Khalaf AK, Mahmoudvand H. Copper nanoparticles: Biosynthesis, characterization, and protoscolicidal effects alone and combined with albendazole against hydatid cyst protoscoleces. Biomed Pharmacother 2021; 136: 111257.
11. Hajjafari A, Sadr S, Santucciu C, Masala G, Bayat M, Lotfalizadeh N, et al. Advances in detecting cystic echinococcosis in intermediate hosts and new diagnostic tools: A literature review. Vet Sci 2024; 11: 227.
12. Albalawi AE, Alanazi AD, Baharvand P, Sepahvand M, Mahmoudvand H. High potency of organic and inorganic nanoparticles to treat cystic echinococcosis: An evidence-based review. Nanomaterials 2020; 10: 2538.
13. Darani HY, Ahmadi F, Zabardast N, Yousefi HA, Shirzad H. Development of a latex agglutination test as a simple and rapid method for diagnosis of Trichomonas vaginalis infection. Avicenna J Med Biotechnol 2010; 2: 63–66.
14. Kiani H, Haghighi A, Seyyedtabaei SJ, Azargashsb E, Zebardast N, Taghipour N, et al. Prevalence, clinical manifestations and genotyping of Cryptosporidium spp. In patients with gastrointestinal illnesses in western Iran. Iran J Parasitol 2017; 12: 169–176.
15. Baykan A, Aydin E, Koc M, Sahin H, Karul A, Baykan M, et al. Hydatid disease: Imaging, treatment, and beyond. Clin Radiol 2025; 80: 106748.
16. Tamarozzi F, Silva R, Fittipaldo VA, Buonfrate D, Gottstein B, Siles-Lucas M. Serology for the diagnosis of human hepatic cystic echinococcosis and its relation with cyst staging: A systematic review of the literature with meta-analysis. PLoS Negl Trop Dis 2021; 15: e0009370.
17. Sharma A, Badea M, Tiwari S, Marty JL. Wearable biosensors: An alternative and practical approach in healthcare and disease monitoring. Molecules 2021; 26: 748.
18. Li L, Wang T, Zhong Y, Li R, Deng W, Xiao X, et al. A review of nanomaterials for biosensing applications. J Mater Chem B 2024; 12: 1168–1193.
19. Kamali H, Golmohammadzadeh S, Zare H, Nosrati R, Fereidouni M, Safarpour H. The recent advancements in the early detection of cancer biomarkers by DNAzyme-assisted aptasensors. J Nanobiotechnology 2022; 20: 438.
20. Jahani Z, Meshgi B, Rajabi-Bzl M, Jalousian F, Hasheminasab S. Improved serodiagnosis of hydatid cyst disease using gold nanoparticle labeled antigen B in naturally infected sheep. Iran J Parasitol 2014; 9: 218.
21. Khalilpour A, Sadjjadi SM, Moghadam ZK, Yunus MH, Zakaria ND, Osman S, et al. Lateral flow test using Echinococcus granulosus native antigen B and comparison of IgG and IgG4 dipsticks for detection of human cystic echinococcosis. Am J Trop Med Hyg 2014; 91: 994.
22. Li P, Jia Z, Lü G. Hydatid detection using the near-infrared transmission angular spectra of porous silicon microcavity biosensors. Sci Rep 2017; 7: 1–8.
23. Li Y, Jia Z, Lv G, Wen H, Li P, Zhang H, et al. Detection of Echinococcus granulosus antigen by a quantum dot/porous silicon optical biosensor. Biomed Opt Express 2017; 8: 3458–3469.
24. Jafari F, Maghsood AH, Fallah M, Jalilvand A, Matini M, Amini B. Design of highly sensitive nano-biosensor for diagnosis of hydatid cyst based on gold nanoparticles. Photodiagnosis Photodyn Ther 2022; 38: 102786.
25. Shirazi S, Hoghooghi-Rad N, Madani R. The comparison between AgB-ELISA and a new method of Nano-ELISA for diagnosis of hydatidosis in sheep. J Hellenic Vet Med Soc 2022; 73: 3629–3634.
26. Khoronko Y, Ermakova L, Pshenichnaya N. Current approaches to diagnostics and treatment of hydatid echinococcosis. Int J Infect Dis 2022; 116: S74.
27. Ebenezer O, Oyetunde-Joshua F, Omotoso OD, Shapi M. Benzimidazole and its derivatives: Recent Advances (2020–2022). Results Chem 2023; 5: 100925.
28. Lee YT, Tan YJ, Oon CE. Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine. Acta Pharm Sin B 2023; 13: 478–497.
29. Chai J-Y, Jung B-K, Hong S-J. Albendazole and mebendazole as anti-parasitic and anti-cancer agents: An update. Korean J Parasitol 2021; 59: 189.
30. Gong Y, Zhou T, Ma R, Yang J, Zhao Y, Pan M, et al. Efficacy and mechanism of energy metabolism dual-regulated nanoparticles (atovaquone-albendazole nanoparticles) against cystic echinococcosis. BMC Infect Dis 2024; 24: 778.
31. Su D, Bai M, Wei C, Long X, Liu X, Shen X, et al. Combining solubilization and controlled release strategies to prepare pH-sensitive solid dispersion loaded with albendazole: In vitro and in vivo studies. Front Vet Sci 2024; 11: 1522856.
32. Koradia KD, Parikh RH, Koradia HD. Albendazole nanocrystals: Optimization, spectroscopic, thermal and anthelmintic studies. J Drug Deliv Sci Technol 2018; 43: 369–378.
33. Zubair T, Rashid SA, Bristy NL, Banik S, Sultana S, Mojumder TJ, et al. Nanocarriers as drug delivery system for chemotherapeutic agents: From inception to clinical implementation. Drug Dev Ind Pharm 2025; 51: 1699-1717.
34. Pasut G. Grand challenges in nano-based drug delivery. Front med technol 2019; 1: 1.
35. Rafiei A, Soltani S, Ramezani Z, Abbaspour MR, Jelowdar A, Kahvaz MS. Ultrastructural changes on fertile and infertile hydatid cysts induced by conventional and solid lipid nanoparticles of albendazole and albendazole sulfoxide. Comp Clin Path 2019; 28: 1045–1053.
36. Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: Structure, composition, types, and clinical applications. Heliyon 2022; 8: e09394.
37. Dymek M, Sikora E. Liposomes as biocompatible and smart delivery systems–the current state. Adv Colloid Interface Sci 2022; 309: 102757.
38. Lv H, Jiang Y, Liao M, Sun H, Zhang S, Peng X. In vitro and in vivo treatments of Echinococcus granulosus with Huaier aqueous extract and albendazole liposome. Parasitol Res 2013; 112: 193–198.
39. Li H, Song T, Shao Y, Aili T, Ahan A, Wen H. Comparative evaluation of liposomal albendazole and tablet-albendazole against hepatic cystic echinococcosis: A non-randomized clinical trial. Medicine 2016; 95: e2237.
40. Zhang H, Zhao J, Chen B, Ma Y, Li Z, Shou X, et al. Pharmacokinetics and tissue distribution study of liposomal albendazole in naturally Echinococcus granulosus infected sheep by a validated UPLC-Q-TOF-MS method. J Chromatogr B 2020; 1141: 122016.
41. Moghadaszadeh M, Khayyati M, Spotin A, Norouzi R, Pagheh AS, Oliveira SMR, et al. Scolicidal and apoptotic activities of 5-hydroxy-1, 4-naphthoquinone as a potent agent against Echinococcus granulosus protoscoleces. Pharmaceuticals 2021; 14: 623.
42. Li Z, Ding S, Li Y. Study on the immunity protection of 14-3-3-MPLA–liposome vaccine against cystic echinococcosis in mice. Front lab Med 2018; 2: 146–151.
43. Xiong X, Li J, Gao D, Sheng Z, Zheng H, Liu W. Cell-membrane biomimetic indocyanine green liposomes for phototheranostics of Echinococcosis. Biosensors 2022; 12: 311.
44. Sorouri N, Soleymani N, Sadr S, Rahdar A, Ebrahimzadeh E, Borji H. Investigating the therapeutic effects of curcumin nanocapsules in hydatid cyst-infected mice. Exp Parasitol 2024; 267: 108860.
45. Pandey S, Shaikh F, Gupta A, Tripathi P, Yadav JS. A recent update: Solid lipid nanoparticles for effective drug delivery. Adv Pharm Bull 2022; 12: 17.
46. Rajpoot K. Solid lipid nanoparticles: A promising nanomaterial in drug delivery. Curr Pharm Des 2019; 25: 3943–3959.
47. Jelowdar A, Rafiei A, Abbaspour MR, Rashidi I, Rahdar M. Efficacy of combined albendazol and praziquntel and their loaded solid lipid nanoparticles components in chemoprophylaxis of experimental hydatidosis. Asian Pac J Trop Biomed 2017; 7: 549–554.
48. Soltani S, Rafiei A, Ramezani Z, Abbaspour MR, Jelowdar A, Kahvaz MS. Evaluation of the hydatid cyst membrane permeability of albendazole and albendazole sulfoxide-loaded solid lipid nanoparticles. Jundishapur J Nat Pharm Prod 2017; 12: 314-319.
49. Aminpour S, Rafiei A, Jelowdar A, Kouchak M. Evaluation of the protoscolicidal effects of albendazole and albendazole loaded solid lipid nanoparticles. Iran J Parasitol 2019; 14: 127.
50. Kohansal K, Rafiei A, Kalantari H, Jelowdar A, Salimi A, Rezaie A, et al. Nephrotoxicity of albendazole and albendazole loaded solid lipid nanoparticles in mice with experimental hydatidosis. Adv Pharm Bull 2022; 12: 102.
51. Faizi F, Mahjub R, Torabi N, Motavallihaghi S, Fallah M. Cationized albumin conjugated solid lipid nanoparticles as vectors for delivery of albendazole against cystic echinococcosis. Parasites Vectors 2024; 17: 542.
52. Kamali H, Nosrati R, Malaekeh-Nikouei B. Nanostructures and their associated challenges for drug delivery (Edited By: Prashant Kesharwani and N.K. Jain). Hybrid nanomaterials for drug delivery. Woodhead Publishing Series in Biomaterials 2022. p. 1-26.
53. Jacob S, Rao R, Gorain B, Boddu SH, Nair AB. Solid lipid nanoparticles and nanostructured lipid carriers for anticancer phytochemical delivery: Advances, challenges, and future prospects. Pharmaceutics 2025; 17: 1079.
54. Ahmadpour E, Godrati-Azar Z, Spotin A, Norouzi R, Hamishehkar H, Nami S, et al. Nanostructured lipid carriers of ivermectin as a novel drug delivery system in hydatidosis. Parasit Vectors 2019; 12: 1-9.
55. Chen C, Gao Q, Luo Y, Zhang G, Xu X, Li Z, et al. The immunotherapy with hMASP-2 DNA nanolipoplexes against echinococcosis in experimentally protoscolex-infected mice. Acta Trop 2020; 210: 105579.
56. Lee M-K. Liposomes for enhanced bioavailability of water-insoluble drugs: In vivo evidence and recent approaches. Pharmaceutics 2020; 12: 264.
57. Guillot AJ, Martínez-Navarrete M, Garrigues TM, Melero A. Skin drug delivery using lipid vesicles: A starting guideline for their development. J Control Release 2023; 355: 624–654.
58. Gatto MS, Johnson MP, Najahi-Missaoui W. Targeted liposomal drug delivery: Overview of the current applications and challenges. Life 2024; 14: 672.
59. Sharma D, Sharma N, Pathak M, Agrawala PK, Basu M, Ojha H. Nanotechnology-based drug delivery systems: Challenges and opportunities (Edited by: Alexandru Mihai Grumezescu). Drug Targeting and Stimuli Sensitive Drug Delivery Systems: Elsevier; 2018. p. 39-79.
60. Satchanska G, Davidova S, Petrov PD. Natural and synthetic polymers for biomedical and environmental applications. Polymers 2024; 16: 1159.
61. Eltaib L. Polymeric nanoparticles in targeted drug delivery: Unveiling the impact of polymer characterization and fabrication. Polymers 2025; 17: 833.
62. Farhadi M, Haniloo A, Rostamizadeh K, Faghihzadeh S. Efficiency of flubendazole-loaded mPEG-PCL nanoparticles: A promising formulation against the protoscoleces and cysts of Echinococcus granulosus. Acta Trop 2018; 187: 190–200.
63. Soleymani N, Sadr S, Santucciu C, Rahdar A, Masala G, Borji H. Evaluation of the in-vitro effects of albendazole, mebendazole, and praziquantel nanocapsules against protoscolices of hydatid cyst. Pathogens 2024; 13: 790.
64. Soleymani N, Sadr S, Santucciu C, Rahdar A, Masala G, Borji H. Investigating the therapeutic effects of albendazole, mebendazole, and praziquantel nanocapsules in hydatid cyst-infected mice. Pathogens 2025; 14: 240.
65. Gültekin Y, Korkmaz Ç, Öztürk N, Filazi A, Deniz A, Vural İ. Development of phytase targeted PLGA nanoparticles loaded with albendazole sulfoxide and praziquantel and evaluation of efficacy on the hydatid cysts. J Drug Deliv Technol 2025; 105: 106662.
66. Aboelsoued D, Toaleb NI, Ibrahim S, Ibrahim S. In vitro and ex vivo protoscolicidal effect of poly(amidoamine) nanoemulsion against Echinococcus granulosus. Sci Rep 2024; 14: 11957.
67. Moheteer A, Zhu J, Pang D, Rao X, Aini N, Aimulajiang K, et al. Dihydroartemisinin-sodium taurocholate-PLGA nanoparticles: A novel therapeutic approach against cystic echinococcosis. Front Pharmacol 2025; 16: 1600525.
68. Kazemi Asl S, Rahimzadegan M, Ostadrahimi R. The recent advancement in the chitosan hybrid-based scaffolds for cardiac regeneration after myocardial infarction. Carbohydr Polym 2023; 300: 120266.
69. Román-Doval R, Torres-Arellanes SP, Tenorio-Barajas AY, Gómez-Sánchez A, Valencia-Lazcano AA. Chitosan: Properties and its application in agriculture in context of molecular weight. Polymers 2023; 15: 2867.
70. Mikušová V, Mikuš P. Advances in chitosan-based nanoparticles for drug delivery. Int J Mol Sci 2021; 22: 9652.
71. Liu Y, Wang Xq, Ren Wx, Chen Yl, Yu Y, Zhang Jk, et al. Novel albendazole–chitosan nanoparticles for intestinal absorption enhancement and hepatic targeting improvement in rats. J Biomed Mater Res B Appl Biomater 2013; 101: 998–1005.
72. Torabi N, Dobakhti F, Faghihzadeh S, Haniloo A. In vitro and in vivo effects of chitosan-praziquantel and chitosan-albendazole nanoparticles on Echinococcus granulosus Metacestodes. Parasitol Res 2018; 117: 2015–2023.
73. Napooni S, Delavari M, Arbabi M, Barkheh H, Rasti S, Hooshyar H, et al. Scolicidal effects of chitosan–curcumin nanoparticles on the hydatid cyst protoscolices. Acta Parasitol 2019; 64: 367–375.
74. Kishik S, Nagati I, El Hayawan I, Ali I, Fawzy M, Ali H. Efficacy of Nigella sativa oil and its chitosan loaded nanoparticles on experimental cystic echinoncoccosis with immunological assessment. Parasitol United J 2020; 13: 172–178.
75. Darvishi MM, Moazeni M, Alizadeh M, Abedi M, Tamaddon A-M. Evaluation of the efficacy of albendazole sulfoxide (ABZ-SO)–loaded chitosan-PLGA nanoparticles in the treatment of cystic echinococcosis in laboratory mice. Parasitol Res 2020; 119: 4233–4241.
76. Firouzeh N, Eslaminejad T, Shafiei R, Faridi A, Fasihi Harandi M. Lethal in vitro effects of optimized chitosan nanoparticles against protoscoleces of Echinococcus granulosus. J Bioact Compat 2021; 36: 237–248.
77. Li Y, Zhu Y, Sha T, Chen Z, Yu M, Zhang F, et al. A multi-epitope chitosan nanoparticles vaccine of canine against Echinococcus granulosus. J Biomed Nanotechnol 2021; 17: 910–920.
78. Amirafshari H, Khazaal RM, Marzban A, Cheraghipour K, Masoori L, Sepahvand A, et al. Therapeutic effects of zinc oxide nanoparticles encapsulated within chitosan-camphor against hydatid cysts through suppressing oxidative stress, inflammation, and DNA damage. Biomed Pharmacother 2025; 188: 118128.
79. Abd El-Latif NF, Elsayad MH, Abdulsalam DE, El-Hadidy W, Khodear GAM, Kazem A, et al. Evaluation of the therapeutic efficacy of albendazole and nitazoxanide loaded chitosan nanoparticles against experimental echinococcosis. J Parasit Dis 2025; 49: 1055-1067.
80. Bhardwaj H, Jangde RK. Current updated review on preparation of polymeric nanoparticles for drug delivery and biomedical applications. Next Nanotechnol 2023; 2: 100013.
81. Nelemans LC, Gurevich L. Drug delivery with polymeric nanocarriers-cellular uptake mechanisms. Materials 2020; 13: 366.
82. Han J, Zhao D, Li D, Wang X, Jin Z, Zhao K. Polymer-based nanomaterials and applications for vaccines and drugs. Polymers 2018; 10: 31.
83. Sánchez L-F, Cánepa J, Kim S, Nakamatsu J. A simple approach to produce tailor-made chitosans with specific degrees of acetylation and molecular weights. Polymers 2021; 13: 2415.
84. Alemu D, Getachew E, Mondal AK. Study on the physicochemical properties of chitosan and their applications in the biomedical sector. Int J Polym Sci 2023; 2023: 5025341.
85. Madni A, Kousar R, Naeem N, Wahid F. Recent advancements in applications of chitosan-based biomaterials for skin tissue engineering. J Bioresour Bioprod 2021; 6: 11–25.
86. Ji M, Long L, Xiong S, Liu Z, Luo J, Liu D. Nanocrystalline drug delivery systems for natural compounds: Progress, challenges and future opportunities. Int J Nanomedicine 2025; 20: 11315–11339.
87. Sood R, Tomar D, Kaushik P, Sharma P, Rani N, Guarve K, et al. Enhanced solubility and increased bioavailability with engineered nanocrystals. Curr Drug Ther 2024; 19: 638–647.
88. Parveen N, Abourehab MAS, Thanikachalam PV, Khar RK, Kesharwani P. Nanocrystals as an emerging nanocarrier for the management of dermatological diseases. Colloids Surf B Biointerfaces 2023; 225: 113231.
89. Paredes AJ, Bruni SS, Allemandi D, Lanusse C, Palma SD. Albendazole nanocrystals with improved pharmacokinetic performance in mice. Ther Deliv 2018; 9: 89–97.
90. Paredes AJ, Camacho NM, Schofs L, Dib A, Zarazaga MdP, Litterio N, et al. Ricobendazole nanocrystals obtained by media milling and spray drying: Pharmacokinetic comparison with the micronized form of the drug. Int J Pharm 2020; 585: 119501.
91. Permana AD, Paredes AJ, Zanutto FV, Amir MN, Ismail I, Bahar MA, et al. Albendazole nanocrystal-based dissolving microneedles with improved pharmacokinetic performance for enhanced treatment of cystic echinococcosis. ACS Appl Mater Interfaces 2021; 13: 38745–38760.
92. Liang Z, Chen M, Yan Y, Chen D, Xie S. Nanocrystal suspensions for enhancing the oral absorption of albendazole. Nanomaterials 2022; 12: 3032.
93. Hu C, Liu Z, Liu C, Zhang Y, Fan H, Qian F. Improvement of antialveolar echinococcosis efficacy of albendazole by a novel nanocrystalline formulation with enhanced oral bioavailability. ACS Infect Dis 2019; 6: 802–810.
94. Fateh R, Norouzi R, Mirzaei E, Nissapatron V, Nawaz M, Khalifeh-Gholi M, et al. In vitro evaluation of albendazole nanocrystals against Echinococcus granulosus protoscolices. Ann Parasitol 2021; 67: 203–212.
95. Montiel Schneider MG, Martín MJ, Otarola J, Vakarelska E, Simeonov V, Lassalle V, et al. Biomedical applications of iron oxide nanoparticles: Current insights progress and perspectives. Pharmaceutics 2022; 14: 204.
96. Abidi H, Ghaedi M, Rafiei A, Jelowdar A, Salimi A, Asfaram A, et al. Magnetic solid lipid nanoparticles co-loaded with albendazole as an anti-parasitic drug: Sonochemical preparation, characterization, and in vitro drug release. J Mol Liq 2018; 268: 11–18.
97. Li Z, Zhang G, Luo Y, Gao Q, Wang J, Chen C, et al. In vivo effect of magnetic microspheres loaded with E2-a in the treatment of alveolar echinococcosis. Sci Rep 2020; 10: 1–8.
98. Kumar P, Chandra P, Verma N, Diksha, Sharma A, Mani M, et al. Gold nanoparticles: An emerging novel technology for targeted delivery system for site-specific diseases. Curr Drug Ther 2025; 20: 345–361.
99. Çolak B, Aksoy F, Yavuz S, Demircili ME. Investigating the effect of gold nanoparticles on hydatid cyst protoscolices under low-power green laser irradiation. Turk J Surg 2019; 35: 314.
100. Barabadi H, Honary S, Ali Mohammadi M, Ahmadpour E, Rahimi MT, Alizadeh A, et al. Green chemical synthesis of gold nanoparticles by using Penicillium aculeatum and their scolicidal activity against hydatid cyst protoscolices of Echinococcus granulosus. Environ Sci Pollut Res Int 2017; 24: 5800–5810.
101. Malekifard F. Solicidal effect of the gold nanoparticle on protoscoleces of hydratid cyst in vitro. Stud Med Sci 2017; 28: 130–137.
102. Napooni S, Arbabi M, Delavari M, Hooshyar H, Rasti S. Lethal effects of gold nanoparticles on protoscolices of hydatid cyst: in vitro study. Comp Clin Path 2019; 28: 143–150.
103. Zarei Z, Azarnivand H, Moazeni M, Bahmani M, Razmjoue D, Oroojalian F. Salvia sclarea L. mediated green synthesis of gold nanoparticles (AuNPs) and evaluation of their antibacterial, anticandidal, and scolicidal properties. Sci Rep 2025; 15: 33392.
104. Zhou X-Q, Hayat Z, Zhang D-D, Li M-Y, Hu S, Wu Q, et al. Zinc oxide nanoparticles: synthesis, characterization, modification, and applications in food and agriculture. Processes 2023; 11: 1193.
105. Deka B, Baruah C, Babu A, Kalita P. Biological and non-conventional synthesis of zinc oxide nanoparticles (ZnO-NPs): their potential applications. J Nanotechnol Nanomater 2022; 3: 79–89.
106. Norouzi R, Hejazy M, Ataei A. Scolicidal activity of zinc oxide nanoparticles against hydatid cyst protoscolices in vitro. Nanomed Res J 2019; 4: 23–28.
107. Mahmmoud SM, Albayati NY, Abdullah AH. Effect of ZnO nanoparticles on protoscolices of Echinococcus granulosus and comparing them with aqueous extract of the grape seeds. Biochem Cell Arch 2020; 20: 2209–2213.
108. Shakibaie M, Khalaf AK, Rashidipour M, Mahmoudvand H. Effects of green synthesized zinc nanoparticles alone and along with albendazole against hydatid cyst protoscoleces. Ann med surg 2022; 78: 103746.
109. Shnawa BH, Hamad SM, Barzinjy AA, Kareem PA, Ahmed MH. Scolicidal activity of biosynthesized zinc oxide nanoparticles by Mentha longifolia L. leaves against Echinococcus granulosus protoscolices. Emergent Mater 2022; 5: 683–693.
110. Cheraghipour K, Azarhazine M, Zivdari M, Beiranvand M, Shakib P, Rashidipour M, et al. Evaluation of scolicidal potential of salicylate coated zinc nanoparticles against Echinococcus granulosus protoscoleces. Exp Parasitol 2023; 246: 108456.
111. Bagherivand A, Jafarirad S, Norouzi R, Rezazadeh E, Karimi A. Zinc oxide/barite nanocomposite from Trachyspermum ammi plant extract: A novel agent against protoscolices of Echinococcus granulosus. J Drug Deliv Technol 2024; 100: 106024.
112. Albalawi Aishah E, Shater Abdullah F, Alanazi Abdullah D, Alsulami Muslimah N, Almohammed Hamdan I. High potency of linalool-zinc oxide nanocomposite as a new agent for cystic echinococcosis treatment. Antimicrob Agents Chemother 2024; 68: e01734–01723.
113. Lashkarizadeh MR, Asgaripour K, Dezaki ES, Harandi MF. Comparison of scolicidal effects of amphotricin B, silver nanoparticles, and Foeniculum vulgare Mill on hydatid cysts protoscoleces. Iran J Parasitol 2015; 10: 206.
114. Rahimi MT, Ahmadpour E, Esboei BR, Spotin A, Koshki MHK, Alizadeh A, et al. Scolicidal activity of biosynthesized silver nanoparticles against Echinococcus granulosus protoscolices. Int J Surg 2015; 19: 128–133.
115. Jalil PJ, Shnawa BH, Hamad SM. Silver nanoparticles: Green synthesis, characterization, blood compatibility and protoscolicidal efficacy against Echinococcus granulosus. Pak Vet J 2021; 41: 393–399.
116. Hamad SM, Shnawa BH, Jalil PJ, Ahmed MH. Assessment of the therapeutic efficacy of silver nanoparticles against secondary cystic echinococcosis in BALB/c mice. Surfaces 2022; 5: 91–112.
117. Nassef NE, Saad A-GE, Harba NM, Beshay EVN, Gouda MA, Shendi SS, et al. Evaluation of the therapeutic efficacy of albendazole-loaded silver nanoparticles against Echinococcus granulosus infection in experimental mice. J Parasit Dis 2019; 43: 658–671.
118. Jari SD, Yousif JJ. Therapeutic effects of silver nanoparticles loaded with albendazole, mebendazole drugs in male albino mice infected with hydatid cysts. Int J Adv Sci Res 2020; 1: 13–18.
119. Aljanabi AA, Al-Mussawi KAM, Bashi AM. Scolicidal effects of silver–copper (core-shell) nanoparticles against Echinococcus granulosus protoscolices in vitro. Ann Rom Soc Cell Biol 2021; 25: 4335–4342.
120. Baghdadi HBA. Potential use of silver nanoparticles green synthesized using Astragalus spinosus extract for treating cystic echinococcosis. Acta Tropica 2024; 257: 107296.
121. Movahedi R, Razmjoue D, Bahmani M, Lysiuk R, Oroojalian F. Eco-friendly green synthesis of silver nanoparticles using Daphne mucronata royle seeds extract and the potential antibacterial, antifungal, and scolicidal activities. ChemistrySelect 2024; 9: e202403423.
122. Zarei Z, Razmjoue D, Moazeni M, Azarnivand H, Oroojalian F. Salvia sclarea L. (Clary Sage) flower extract-mediated green synthesis of silver nanoparticles and their characterization, antibacterial, antifungal, and scolicidal activities against Echinococcus granulosus. Microbe 2024; 5: 100216.
123. Bagherivand A, Jafarirad S, Norouzi R, Karimi A. Scolicidal and apoptotic effects of phyto- and chemically synthesized silver/boehmite nanocomposites on Echinococcus granulosus protoscoleces. Biomater Adv 2024; 157: 213723.
124. Mahmoudvand H, Harandi MF, Shakibaie M, Aflatoonian MR, ZiaAli N, Makki MS, et al. Scolicidal effects of biogenic selenium nanoparticles against protoscolices of hydatid cysts. Int J Surg 2014; 12: 399-403.
125. Nematollahi A, Shahbazi P, Rafat A, Ghanbarlu M. Comparative survey on scolicidal effects of selenium and silver nanoparticles on protoscolices of hydatid cyst. Open Vet J 2018; 8: 374–377.
126. Mohammed SA, Ali AA. Effect of selenium nanoparticles against protoscoleces of Echinococcus granulosus in vitro and hydatid cysts in mice. Iraqi J Vet Sci 2022; 36: 195-202.
127. Alshehri ZS, Alanazi AD, Baghdadi HBA. Therapeutic effects of green synthesized copper nanoparticles against hydatid disease through inhibiting inflammation, oxidative stress, and apoptosis. Acta Parasitol 2025; 70: 73.
128. Bagherivand A, Jafarirad S, Norouzi R, Karimi A. Biomedical behaviors of CuO/γ-alumina/chitosan nanocomposites: Scolicidal and apoptotic effects on hydatid cysts protoscolices. Int J Biol Macromol 2024; 263: 130515.
129. Navvabi A, Homaei A, Khademvatan S, Ansari MHK, Keshavarz M. Combination of TiO2 nanoparticles and Echinometra mathaeis gonad extracts: In vitro and in vivo scolicidal activity against hydatid cysts. Biocatal Agric Biotechnol 2019; 22: 101432.
130. Ibrahim AA-J. Scolicidal activity of zirconium oxide (ZrO2) nanoparticles against protoscolices of hydatid cysts. Indian J Forensic Med Toxicol 2020; 14: 409.
131. Ibrahim AAJ. Study the efficacy of titanium oxide (TiO2) nanoparticles against protoscolices of hydatid cysts. Ann Trop Med Public Health 2020; 23: 60-64.
132. Shnawa BH, Jalil PJ, Hamad SM, Ahmed MH. Antioxidant, protoscolicidal, hemocompatibility, and antibacterial activity of nickel oxide nanoparticles synthesized by Ziziphus spina-christi. Bionanoscience 2022; 12: 1264–1278.
133. Aryamand S, Khademvatan S, Tappeh KH, Heshmatian B, Jelodar A. In vitro and in vivo scolicidal activities of Holothuria leucospilota extract and CeO2 nanoparticles against hydatid cyst. Iran J Parasitol 2019; 14: 269.
134. Khizar S, Alrushaid N, Khan FA, Zine N, Jaffrezic-Renault N, Errachid A, et al. Nanocarriers based novel and effective drug delivery system. Int J Pharm 2023; 632: 122570.
135. Liu S, Wen X, Zhang X, Mao S. Oral delivery of biomacromolecules by overcoming biological barriers in the gastrointestinal tract: An update. Expert Opin Drug Deliv 2023; 20: 1333–1347.
136. Spirescu VA, Chircov C, Grumezescu AM, Vasile BȘ, Andronescu E. Inorganic nanoparticles and composite films for antimicrobial therapies. Int J Mol Sci 2021; 22: 4595.
)